· Weekly signal · MRNA
Moderna Inc (MRNA) suffers a 12.5% weekly break as momentum weakens
The biotechnology stock’s latest weekly close leaves the one-month move under pressure, even as the longer 12-week return remains positive.
Moderna Inc (MRNA) closed the latest week at 54.07 USD, down -12.5% for the period and -19.6% over four weeks. The move cut into a broader rebound that still shows a 19.2% gain over 12 weeks.
The 52-week weekly price path points to a pullback rather than live intraday action. Market Dynamics show pressure at 0.62, while Relative Strength at 23.4 keeps the setup weak despite an active trend signal.